Managing myeloma with limited resources in the era of novel drugs

Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1080/10428194.2018.1476692

Related publications

Article2013

IgD Myeloma: Clinical Features and Outcome In The Era Of Novel Agents

Flora Zagouri, Efstathios Kastritis, Argiris Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Sosana Delimpasi, Panagiotis Repousis, Stavroula Giannouli, Ευδοκία Μανδαλά, Evangelos Terpos, Meletios A Dimopoulos

Article2013

Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents

Flora Zagouri, Efstathios Kastritis, Argiris Symeonidis, Nikolaos Giannakoulas, Eirini Katodritou, Sosana Delimpasi, Panagiotis Repousis, Evangelos Terpos, Meletios A Dimopoulos

Article2011

Advances in Imaging and the Management of Myeloma Bone Disease

Evangelos Terpos, Lia A. Moulopoulos, Meletios A Dimopoulos

Article2014

Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents

Morie A. Gertz, Evangelos Terpos, Angela Dispenzieri, Shaji Kumar, Rupin Shah, Robert Z. Orlowski, Efstathios Kastritis, Meletios A Dimopoulos, Jatin J. Shah

Article2018

Prognostic factors for multiple myeloma in the era of novel therapies

Dimitrios C. Ziogas, Meletios A Dimopoulos, Efstathios Kastritis